Brazilian regulator Anvisa had in March denied a certificate for good manufacturing practices to Bharat Biotech citing certain violations of GMP at Bharat Biotech facility. Anvisa’s clearance is a necessary step for the country’s process of authorising this vaccine for emergency use.Bharat Biotech submits fresh request before Brazilian regulator for Covaxin GMP certificate
Brazilian regulator Anvisa had in March denied a certificate for good manufacturing practices to Bharat Biotech citing certain violations of GMP at Bharat Biotech facility. Anvisa’s clearance is a necessary step for the country’s process of authorising this vaccine for emergency use.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment